Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001592776-17-000001
Filing Date
2017-08-07
Accepted
2017-08-07 13:21:27
Documents
1
Effectiveness Date
2017-08-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8192
  Complete submission text file 0001592776-17-000001.txt   9308
Mailing Address C/O INST. FOR PHARMACEUTICAL DISCOVERY 21 BUSINESS PARK DRIVE BRANFORD CT 06405
Business Address C/O INST. FOR PHARMACEUTICAL DISCOVERY 21 BUSINESS PARK DRIVE BRANFORD CT 06405 (203) 819-2322
Ancera, Inc. (Filer) CIK: 0001592776 (see all company filings)

EIN.: 462706894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-292242 | Film No.: 171010911